Moreover, p38 MAPK activation in mouse liver dramatically reduced tumor development (23) thus suggesting p38 MAPK activity mitigation by CAR-Gadd45β complex may be causing the observed HCC development. The gene discussed is GADD45B; the disease is hepatocellular carcinoma.